Intercontinental Exchange Inc. Common Stock vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Intercontinental Exchange Inc. Common Stock trades at $156.51 (market cap $87.21B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.18 (market cap $6.04B). The key difference: Intercontinental Exchange Inc. Common Stock is far larger — about 14.4× Iovance Biotherapeutics Inc. Common Stock's market cap, and Intercontinental Exchange Inc. Common Stock pays a 1.34% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals.
| ICE | IOVA | |
|---|---|---|
Market Cap | $87.21B | $6.04B |
Volume | 2,029,112 | 14,805,993 |
Sector | Financials | Health |
52-Week High | $175.10 | $14.82 |
52-Week Low | $122.91 | $1.81 |
Enterprise Value | $105.12B | $5.97B |
Dividend Yield | 1.34% | — |
Typical Hold Time | — | 0 Days |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Intercontinental Exchange provides technology and data services for financial institutions, corporations, and governments. Its businesses include exchanges and clearing, fixed-income data and analytics, and mortgage technology.
Read more on ICE →Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →